WHO slams US-funded newborn vaccine trial as "unethical"
The World Health Organization on Friday released a formal statement blasting a US-funded vaccine trial as "unethical," because it would withhold an established, safe, and potentially lifesaving vaccine against hepatitis B from some newborns in Guinea-Bissau, Africa.
"In its current form, and based on publicly available information, the trial is inconsistent with established ethical and scientific principles," the WHO concluded, after providing a bullet-point list of reasons the trial was harmful and low quality.
The trial has drawn widespread condemnation from health experts since notice of the US funding was published in the Federal Register in December. The notice revealed that the Centers for Disease Control and Prevention—under anti-vaccine Health Secretary Robert F. Kennedy Jr.—had awarded $1.6 million to Danish researchers for their non-competitive, unsolicited proposal to conduct the trial.